Long-term outcomes of adrenal insufficiency (AI) due to anti–PD(L)-1 immune checkpoint inhibitors (ICI) among patients with cancer.

Authors

null

Ben Nguyen

SUNY Downstate Medical Center, Brooklyn, NY

Ben Nguyen , Neil J. Shah , Andrea Knezevic , Samantha Newman , Kelly N. Fitzgerald , Ritesh Kotecha , Chung-Han Lee , Maria Isabel Carlo , David Henry Aggen , Darren R. Feldman , Natalie Shapnik , Robert J. Motzer , Martin H Voss , Monica Girotra

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Late and Long-Term Adverse Effects

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12092)

DOI

10.1200/JCO.2022.40.16_suppl.12092

Abstract #

12092

Poster Bd #

338

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Annual Meeting

Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment.

Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment.

First Author: Sarah Kim

First Author: Evangelia Vlachou

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors.

Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors.

First Author: Ryo Morikawa

First Author: J. Randolph Hecht